NUBEQA (darolutamide) 300 mg tablets logo Bayer logo

Now FDA approved to also treat metastatic prostate cancer that is hormone sensitive (mHSPC) when used in combination with docetaxel

Learn more

Even with rising PSA on hormone therapy*

NUBEQA HELPS YOU LIVE FOR WHAT YOU LOVE

Recreated photos of NUBEQA (darolutamide) patient and his spouse holding surfboards at the ocean.
Recreated photos of NUBEQA (darolutamide) patient and his spouse holding surfboards at the ocean.

The clinical study for NUBEQA was designed to measure metastasis-free survival (MFS) and also overall survival (OS). NUBEQA extended OS by lowering the risk of death by 31% compared with hormone therapy alone.

NUBEQA® (darolutamide) is a prescription medicine used to treat adults with prostate cancer:

  • that has not spread to other parts of the body and no longer responds to medical or surgical treatment that lowers testosterone (nmCRPC)
  • that has spread to other parts of the body and responds to medical or surgical treatment that lowers testosterone (mHSPC), in combination with docetaxel

It is not known if NUBEQA is safe and effective in women or children.

NUBEQA CAN HELP

If hormone therapy* no longer controls your prostate cancer that has not spread to other parts of the body

AND

Your PSA is still rising and your testosterone levels are low

*Hormone therapy includes gonadotropin-releasing hormone (GnRH), such as Lupron Depot® (drug treatment), or surgery that lowers testosterone.

LEARN FROM THIS RESOURCE

Find out what NUBEQA can offer you, and get resources and support to help you along the way.

NUBEQA (darolutamide) patient brochure thumbnail with download icon.

NUBEQA FREE TRIAL PROGRAM

Patients who are NEW to NUBEQA can get 1 month of free medication.

1

MONTH FREE

ASK YOUR DOCTOR IF NUBEQA IS RIGHT FOR YOU

Pronounced (new-BEH-kah)

The NUBEQA Free Trial Program provides 1 month's supply of NUBEQA at no cost to patients who meet the program eligibility requirements and agree to the terms and conditions. For full terms and conditions, please call Access Services by BayerTM at 1-800-288-8374.

Lupron Depot is a registered trademark of AbbVie Inc.

PSA=prostate-specific antigen.

Man running in blue shirt, shorts and shoes. Trees and blue and orange stripe are in the background.

STAY IN THE KNOW

If you would like to receive tools, tips, and NUBEQA information and support, sign up to receive future updates.

WHY NUBEQA?

NUBEQA has clinically proven effectiveness and tolerability. It can help delay the spread of prostate cancer to other parts of the body when you are no longer responding to a medical or surgical treatment that lowers testosterone.

Learn what NUBEQA can do

IMPORTANT SAFETY INFORMATION

Before taking NUBEQA, tell your healthcare provider about all your medical conditions, including if you:

  • have heart problems, high blood pressure, diabetes, or high amounts of fat or cholesterol in your blood (dyslipidemia)
  • have a history of seizures, brain injury, stroke, or brain tumors
  • have kidney or liver problems
  • are pregnant or plan to become pregnant. NUBEQA can cause harm to your unborn baby and loss of pregnancy (miscarriage)
  • have a partner who may become pregnant. Males who have female partners who may become pregnant should use effective birth control (contraception) during treatment and for 1 week after the last dose of NUBEQA. Talk with your healthcare provider about birth control methods
  • are breastfeeding or plan to breastfeed. It is not known if NUBEQA passes 
    into breast milk

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. NUBEQA may affect the way other medicines work and other medicines may affect how NUBEQA works.

You should not start or stop any medicine before you talk with the healthcare provider that prescribed NUBEQA.

Know the medicines you take. Keep a list of them with you to show to your healthcare provider and pharmacist when you get a new medicine.

NUBEQA may cause serious side effects, including:

  • Heart disease. Blockage of the arteries in the heart (ischemic heart disease) that can lead to death has happened in some people during treatment with NUBEQA. Your healthcare provider will monitor you for signs and symptoms of heart problems during your treatment with NUBEQA. Call your healthcare provider or get medical help right away if you get chest pain or discomfort at rest or with activity, or shortness of breath during your treatment with NUBEQA
  • Seizure. Treatment with NUBEQA may increase your risk of having a seizure. You should avoid activities where a sudden loss of consciousness could cause serious harm to yourself or others. Tell your healthcare provider right away if you have loss of consciousness or seizure

The most common side effects of NUBEQA in people with nmCRPC include:

  • increase in liver function tests
  • decreased white blood cells
    (neutropenia)
  • feeling more tired than usual
  • arm, leg, hand, or foot pain
  • rash

The most common side effects of NUBEQA when used in combination with docetaxel in people with mHSPC include:

  • constipation
  • decreased appetite
  • rash
  • bleeding
  • weight gain
  • high blood pressure
  • decreased red blood cells (anemia)
  • high blood sugar levels
  • decreased white blood cells
  • increase in liver function tests
  • low blood calcium levels

NUBEQA may cause fertility problems in males, which may affect the ability to father children. Talk to your healthcare provider if you have concerns about fertility.

These are not all the possible side effects of NUBEQA.

Call your healthcare provider for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

Please see additional Important Safety Information and the full Prescribing Information.

WHAT IS NUBEQA®?

NUBEQA® (darolutamide) is a prescription medicine used to treat adults with prostate cancer:

  • that has not spread to other parts of the body and no longer responds to medical or surgical treatment that lowers testosterone (non-metastatic castration-resistant prostate cancer or nmCRPC)
  • or
  • that has spread to other parts of the body and responds to medical or surgical treatment that lowers testosterone (metastatic hormone-sensitive prostate cancer or mHSPC), in combination with docetaxel

It is not known if NUBEQA is safe and effective in women or children.